SECreport
Form 4 Revance Therapeutics, For: Mar 21 Filed by: Joshi Abhay
Last revance therapeutics earnings: 5/8 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.revance.com
| IMPACT SNAPSHOT | EVENT TIME: | RVNC | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
RVNC alerts
RVNC alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
RVNC alerts
High impacting REVANCE THERAPEUTICS news events
Weekly update
A roundup of the hottest topics
RVNC
NEWS
NEWS
- Revance Therapeutics Inc (NASDAQ: RVNC) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating.[MarketBeat]
- Revance Therapeutics to Release Second Quarter 2018 Financial Results on Thursday, August 2, 2018[Business Wire]
- Revance Therapeutics Inc (NASDAQ: RVNC) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating.[MarketBeat]
- Revance Therapeutics Inc (NASDAQ: RVNC) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $33.00 price target on the stock.[MarketBeat]
- Revance Therapeutics Inc (NASDAQ: RVNC) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating.[MarketBeat]
- More
RVNC
SEC Filings
SEC Filings
- 7/6/18 - Form 4
- 7/3/18 - Form 4
- 7/3/18 - Form 4
- RVNC's page on the SEC website
- More